Anaptysbio (ANAB) Selling, General & Administrative (2016 - 2026)
Anaptysbio's Selling, General & Administrative was $26.2 million in Q1 2026, up 85.4% from $14.13 million a year earlier and up 66.0% from the prior quarter.
Powered by 
Analysis
Anaptysbio (ANAB) Selling, General & Administrative (2016 - 2026) Analysis & Trends
On a trailing twelve-month basis, Anaptysbio's Selling, General & Administrative was $62.81 million through Mar 31, 2026, up 42.2% year-over-year; for FY2025, it came in at $50.74 million, up 19.7% from FY2024.
- Selling, General & Administrative has now increased for ten consecutive years, with a five-year compound annual growth rate of 21.9% (FY2020 to FY2025).
- In earlier years, Selling, General & Administrative was $42.39 million in FY2024 (+1.1%), $41.95 million in FY2023 (+14.5%), $36.64 million in FY2022 (+70.5%) and $21.49 million in FY2021 (+14.0%).
- The Q1 2026 figure marks the highest quarterly Selling, General & Administrative in data going back to Q1 2016.
- Compared with a year earlier, Selling, General & Administrative was higher in five of the last eight quarters, with growth averaging 19.5%.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q1 2022 (growth of 88.1%); the worst was Q2 2024 (a decline of 13.0%).
- Per Business Quant data, ANAB's Selling, General & Administrative in the three quarters before Q1 2026 was $15.79 million (Q4 2025), $10.21 million (Q3 2025) and $10.61 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Anaptysbio | 1.41 Bn | 296.12 Mn | - | 26.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 26.20 Mn |
| Dec 31, 2025 | 15.79 Mn |
| Sep 30, 2025 | 10.21 Mn |
| Jun 30, 2025 | 10.61 Mn |
| Mar 31, 2025 | 14.13 Mn |
| Dec 31, 2024 | 10.19 Mn |
| Sep 30, 2024 | 10.56 Mn |
| Jun 30, 2024 | 9.30 Mn |
| Mar 31, 2024 | 12.34 Mn |
| Dec 31, 2023 | 10.28 Mn |
| Sep 30, 2023 | 10.17 Mn |
| Jun 30, 2023 | 10.68 Mn |
| Mar 31, 2023 | 10.82 Mn |
| Dec 31, 2022 | 9.41 Mn |
| Sep 30, 2022 | 8.86 Mn |
| Jun 30, 2022 | 8.17 Mn |
| Mar 31, 2022 | 10.20 Mn |
| Dec 31, 2021 | 5.39 Mn |
| Sep 30, 2021 | 5.43 Mn |
| Jun 30, 2021 | 5.25 Mn |
API Access
Anaptysbio Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ANAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ANAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ANAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();